Welch Daniel G's Form 4/A amendment
AmendedSeagen Inc. (SGEN) · filed Apr 12, 2023
- Accession no.
- 0000899243-23-011219
- Filed
- Apr 12, 2023
- Rule 10b5-1 plan
- Checked
- Original filed
- Apr 5, 2023
This filing lists no transactions. It carries over 21 transactions from the original filing that it did not restate. Open-market sales total $6.25M.
This amendment restates part of 0000899243-23-010823 (filed Apr 5, 2023). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Welch Daniel GCIK 0001206199 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0000899243-23-010823 (filed Apr 5, 2023).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | Common Stock | MOption exerciseAcquired | +995 | $38.82 | +$38,625.9 | 7,894 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −995 | $200.11F3 | −$199,109.45 | 6,899 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseAcquired | +5,680 | $66.60 | +$378,288 | 12,579 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −5,680 | $200.71F4 | −$1,140,032.8 | 6,899 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseAcquired | +3,575 | $66.60 | +$238,095 | 10,474 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −3,575 | $201.59F5 | −$720,684.25 | 6,899 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseAcquired | +5 | $66.60 | +$333 | 6,904 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −5 | $202.49F6 | −$1,012.45 | 6,899 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseAcquired | +7,158 | $56.77 | +$406,359.66 | 14,057 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −7,158 | $202.51F7 | −$1,449,566.58 | 6,899 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseAcquired | +112 | $56.77 | +$6,358.24 | 7,011 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −112 | $203.05 | −$22,741.6 | 6,899 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −817 | $200.45F8 | −$163,767.65 | 6,082 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −851 | $201.51F9 | −$171,485.01 | 5,231 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −1,082 | $202.54F10 | −$219,148.28 | 4,149 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −3,124 | $200.45F8 | −$626,205.8 | 19,936 | Indirect | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −3,317 | $201.51F9 | −$668,408.67 | 16,619 | Indirect | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −4,284 | $202.54F10 | −$867,681.36 | 12,335 | Indirect |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | Common Stock | MOption exerciseDisposed | −995 | $0.00 | $0 | 0 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseDisposed | −9,260 | $0.00 | $0 | 0 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseDisposed | −7,270 | $0.00 | $0 | 1,990 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F3
Reflects sales of common stock executed in multiple transactions at prices ranging from $200.10 to $200.43. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.
- F4
Reflects sales of common stock executed in multiple transactions at prices ranging from $200.27 to $201.26. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.
- F5
Reflects sales of common stock executed in multiple transactions at prices ranging from $201.28 to $202.03. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.
- F6
Reflects sales of common stock executed in multiple transactions at prices ranging from $202.32 to $202.60. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.
- F7
Reflects sales of common stock executed in multiple transactions at prices ranging from $201.92 to $202.91. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.
- F8
Reflects sales of common stock executed in multiple transactions at prices ranging from $200.10 to $201.07. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 2 transactions in Table I.
- F9
Reflects sales of common stock executed in multiple transactions at prices ranging from $201.10 to $202.05. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 2 transactions in Table I.
- F10
Reflects sales of common stock executed in multiple transactions at prices ranging from $202.11 to $203.05. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 2 transactions in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This amendment to the Form 4 originally filed on April 5, 2023 is being filed solely to check the Rule 10b5-1(c) Transaction Indication box and provide related disclosure. Sales reported in this Form 4 were effected pursuant to written plans, entered into on September 7, 2022, that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
- F2
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.